title: [Result of Panzytrat 25000 therapy following total gastrectomy].
abstract: Thirteen patients who had undergone total gastrectomy because of gastric cancer in 11 cases and gastric lymphoma in 2 cases (6 female, 7 male) at the 3rd Department of Surgery, Semmelweis University, Medical School have been followed up. The length of follow up period varied between 7.5 months and six years. Vitamin B12 substitution was applied in each case (300 micrograms/month). In 6 cases early temporary iron substitution was necessary. Regular pancreatic enzyme substitution (pancreatin) was used during meals in these patients. At the beginning Kreon (Chinoin) or Neo-Panpur (Egis) treatment was applied. Since April 1996 the patients have been treated by Panzytrat 25,000 (Knoll) which has higher enzyme content comparing with the previous ones. Following gastrectomy the digestion and absorption improved due to pancreatic enzyme substitution and the body weight increased. The serum albumin and cholesterol levels elevated significantly, while the serum uric acid levels did not changed. The iron absorption improved, patients did not require iron substitution later, except two cases. One of them needed transitoric and the other continuous iron substitution. Side effects were recorded in six cases. One of the 13 patients stopped application of Panzytrat 25,000 because of epigastric pain among other side effects (2 epigastric pain, 2 hyperuric state, 2 frequent discharge of stool) and returned to well tolerated Neo-Panpur.
authors.affiliation: III. Sebészeti Klinika, Semmelweis Orvostudományi Egyetem, Budapest.
authors.forename: P
authors.initials: P
authors.lastname: Kriváchy
authors.forename: A
authors.initials: A
authors.lastname: Bálint
authors.forename: M
authors.initials: M
authors.lastname: Máté
authors.forename: M
authors.initials: M
authors.lastname: Ihász
mesh_terms: D005260:Female; D005743:Gastrectomy / Q000379:methods*; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D008297:Male; D010194:Pancreatin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011182:Postoperative Care; D013274:Stomach Neoplasms / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D010194:Pancreatin; D007501:Iron